Interstitial lung disease is a dominant feature in patients with circulating myositis-specific antibodies

BACKGROUND: Many patients with polymyositis (PM) or dermatomyositis (DM) have circulating myositis-specific antibodies (MSAs). Interstitial lung disease (ILD) is a common manifestation of PM/DM, and it can even precede the onset of characteristic muscle or skin manifestations. Furthermore, there app...

Descripción completa

Detalles Bibliográficos
Autores principales: Misra, Abhinav K., Wong, Nathan L., Healey, Terrance T., Lally, Edward V., Shea, Barry S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591876/
https://www.ncbi.nlm.nih.gov/pubmed/34775966
http://dx.doi.org/10.1186/s12890-021-01737-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591876/
https://www.ncbi.nlm.nih.gov/pubmed/34775966
http://dx.doi.org/10.1186/s12890-021-01737-7

Ejemplares similares